Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple-negative metastatic breast cancer

Oral metronomic chemotherapy may target tumor cells indirectly via antiangiogenic activity, restoration of anticancer immune response, or induction of tumor dormancy. We initiated the single-center, randomized, open-label, phase II study to determine whether the addition of metronomic cyclophosphami...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncotarget
Auteurs principaux: Zhang, Jian, Wang, Leiping, Wang, Zhonghua, Wang, Biyun, Cao, Jun, Lv, Fangfang, Zhang, Sheng, Shao, Zhimin, Hu, Xichun
Format: Artigo
Langue:Inglês
Publié: Impact Journals LLC 2017
Sujets:
Clinical Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5668065/
https://ncbi.nlm.nih.gov/pubmed/29108332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18539
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires